Filing Details
- Accession Number:
- 0000899243-20-032920
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-07 20:05:27
- Reporting Period:
- 2020-12-04
- Accepted Time:
- 2020-12-07 20:05:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1513818 | Aravive Inc. | ARAV | Pharmaceutical Preparations (2834) | 264106690 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1753078 | Vinay Shah | C/O Aravive, Inc., River Oaks Tower, 3730 Kirby Drive, Suite 1200 Houston TX 77098 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-04 | 8,000 | $5.76 | 189,842 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $5.73 to $5.79, inclusive. The reporting person undertakes to provide Aravive, Inc., any security holder of Aravive, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.
- Includes an aggregate of 3,236 shares acquired under the Aravive, Inc. 2014 Employee Stock Purchase Plan, of which 416 shares were acquired on each of May 15, 2019, November 15, 2019 and May 15, 2020, respectively and 1,988 shares were acquired on November 13, 2020.
Billionaire Hedge Funds
